Clinical Trial

Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry

Study acronym: SPIDER
Recruiting
View on ClinicalTrials.gov →
Summary
Given the lack of large multicenter datasets in the context of Spinal arteriovenous fistula, the strength of the evidence surrounding this rare disease is limited. SPIDER hence aims to address that by compiling patient-level data from centers all around the world.
Trial Details
NCT Number NCT07574645
Lead Sponsor Thomas Jefferson University
Conditions Spinal Dural Arteriovenous Fistula
Enrollment 1,000 participants
Start Date 2026-01-05
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-08